|
Volumn 292, Issue 3, 1975, Pages 117-122
|
L-Phenylalanine Mustard (L-PAM) in the Management of Primary Breast Cancer: A Report of Early Findings
a a a a a a a a a a a a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
MELPHALAN;
PLACEBO;
BONE MARROW;
BREAST;
BREAST CANCER;
CANCER CHEMOTHERAPY;
CANCER SURGERY;
CANCER THERAPY;
CARCINOMA;
CLINICAL STUDY;
CLINICAL TRIAL;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
DRUG THERAPY;
DRUG TOXICITY;
HUMAN;
MAJOR CLINICAL STUDY;
MASTECTOMY;
MENOPAUSE;
METASTASIS;
ORAL DRUG ADMINISTRATION;
RANDOMIZED CONTROLLED TRIAL;
THERAPY;
ADULT;
ARTICLE;
BONE MARROW CELL;
BREAST TUMOR;
DRUG EFFECT;
DRUG SCREENING;
FEMALE;
LYMPH NODE;
PATHOLOGY;
BONE MARROW;
BONE MARROW CELLS;
BREAST NEOPLASMS;
CLINICAL TRIALS;
DRUG EVALUATION;
FEMALE;
HUMAN;
LYMPH NODES;
MELPHALAN;
MENOPAUSE;
MIDDLE AGE;
SUPPORT, U.S. GOV'T, P.H.S.;
|
EID: 0016409129
PISSN: 00284793
EISSN: 15334406
Source Type: Journal
DOI: 10.1056/NEJM197501162920301 Document Type: Article |
Times cited : (601)
|
References (8)
|